Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03241459 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
A NA study, sponsored by SurModics.
- Completed
- Registry status
- NA
- Development phase
- 446
- Enrollment target
NCT03241459 is a NA study that has completed, run by SurModics. The registered enrollment target is 446 participants.
The verdict
NCT03241459, a NA study, has completed, sponsored by SurModics.
- COMPLETED
- Registry status
- NA
- Development phase
- 446 participants
- Enrollment target
Study Summary
To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease (PAD) due to stenosis of the femoral and/or popliteal arteries.
Interventions
- DEVICE Surmodics SurVeil DCB
- DEVICE Medtronic IN.PACT Admiral DCB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2017-10-23 |
| Est. Completion | 2024-09-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03241459
The ClinicalTrials.gov registry entry for NCT03241459 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 446 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SurModics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Surmodics SurVeil DCB is the first listed.
NCT03241459 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03241459 about?
NCT03241459 is a clinical study titled "Safety and Efficacy of the SurVeil™ Drug-Coated Balloon". To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease (PAD) due to stenosis of the femoral and/or popliteal arteries.
What is the current status of trial NCT03241459?
This trial is currently completed. It is a NA study. The enrollment target is 446 participants. The study started on 2017-10-23. Estimated completion is 2024-09-17.
What interventions are being tested in trial NCT03241459?
The interventions under investigation include: Surmodics SurVeil DCB (DEVICE), Medtronic IN.PACT Admiral DCB (DEVICE).
Who is sponsoring clinical trial NCT03241459?
This trial is sponsored by SurModics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.